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Abstract
Background: To understand cardiac and skeletal muscle function, it is important to define and explore their
molecular constituents and also to identify similarities and differences in the gene expression in these two different
striated muscle tissues. Here, we have investigated the genes and proteins with elevated expression in cardiac and
skeletal muscle in relation to all other major human tissues and organs using a global transcriptomics analysis
complemented with antibody-based profiling to localize the corresponding proteins on a single cell level.
Results: Our study identified a comprehensive list of genes expressed in cardiac and skeletal muscle. The genes
with elevated expression were further stratified according to their global expression pattern across the human body
as well as their precise localization in the muscle tissues. The functions of the proteins encoded by the elevated
genes are well in line with the physiological functions of cardiac and skeletal muscle, such as contraction, ion
transport, regulation of membrane potential and actomyosin structure organization. A large fraction of the
transcripts in both cardiac and skeletal muscle correspond to mitochondrial proteins involved in energy
metabolism, which demonstrates the extreme specialization of these muscle tissues to provide energy for
contraction.
Conclusions: Our results provide a comprehensive list of genes and proteins elevated in striated muscles. A
number of proteins not previously characterized in cardiac and skeletal muscle were identified and localized to
specific cellular subcompartments. These proteins represent an interesting starting point for further functional
analysis of their role in muscle biology and disease.
Keywords: Transcriptome, Proteome, Cardiac and skeletal muscle
Background
Cardiac and skeletal muscles are both striated muscles
composed of repeated units called sarcomeres, crossed
with a regular pattern of fine red and white lines giving
the muscles their distinctive striated appearance and
their name. The cells are rich in mitochondria and contain
to a large extent myosin and actin proteins, signifying
different regions of the sarcomeres. While skeletal muscle
consists of parallel linear fibers, the cardiac muscle cells
(cardiomyocytes) are arranged in fibers exhibiting cross-
striations formed by alternating segments of thick and
thin protein filaments. For rhythmical and synchronized
contraction, cardiomyocytes form a functional syncytium
via intercalated discs, where the membranes of adjacent
cells are situated closely together. Intercalated discs are
unique for the heart and visible as clearly distinguishable
bands between cardiomyocytes. In addition to muscle fi-
bers and vasculature, the heart also includes streaks of
connective tissue and cuffs of adipose tissue surrounding
the smaller vessels. Skeletal muscles consist of large
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multinucleated myocytes called syncytia, formed during
development via fusion of myotubes. There are two main
muscle fiber types (slow type I and fast type II) depending
on the dominant type of myosin present. Skeletal muscles
are attached to bone and contract voluntarily (via nerve
stimulation) as opposed to cardiac muscle and smooth
muscle. In addition to the muscle fibers, skeletal muscle
samples also contain streaks of adipose tissue and con-
nective tissue with fibroblasts. Skeletal muscle is highly
vascularized with a fine network of capillary endothelial
cells running in between the fibers.
Detailed knowledge of the molecular constituents of
striated muscles under normal conditions is essential to
understand the cellular interactions in health and disease.
Thus far, several transcriptomics signatures on diseased
hearts have been performed, primarily using animal
models or human serum [1–3]. These studies have pro-
vided important insights into disease pathogenesis and
drug development, however, until date, no detailed
characterization of the transcriptome and proteome in
normal human striated muscle tissues has been performed
using a genome-wide analysis of both the transcripts and
the corresponding protein profiles. In addition, no com-
prehensive study has yet been performed to compare the
cardiac and skeletal muscle to identify both unique and
shared proteins involved in muscle biology.
Here, we generated next generation sequencing (RNA-
seq) data for skeletal muscle tissue and performed an
extended analysis based on the RNA-seq data of 28 dif-
ferent tissues involving 100 samples, including four and
five individual samples from cardiac and skeletal muscle,
respectively. This approach has been used for identifying
a comprehensive list of several hundred genes elevated
in striated muscles as compared to other analyzed tis-
sues, representing all major organs in the human body.
Subsequently, an antibody-based approach using tissue
microarrays and immunohistochemistry was used to
localize the elevated proteins to different subcompart-
ments of heart and skeletal muscle on a single cell level.
Results
The transcriptomic analysis
A transcriptomic analysis was performed using deep se-
quencing (RNA-seq) on five skeletal muscle samples.
These were compared with our previously reported tran-
scriptomic analysis on 27 fresh frozen tissue types in-
cluding four heart muscle samples [4]. This resulted in
altogether 100 samples corresponding to 28 tissue types.
The normalized mRNA abundance was calculated as
FPKM-values with a cutoff of FPKM = 1, roughly corre-
sponding to one mRNA molecule per average cell in the
sample [5]. The most abundant genes in muscle tissues
were mitochondrial genes expressed in all tissue types,
with the highest mRNA abundance (FPKM = 20,737)
observed by the mitochondrial gene MT-CO1 in cardiac
muscle. An analysis of the global expression profiles
using hierarchical clustering and a correlation heat map
from all the 100 tissue samples are displayed in Fig. 1.
The heat map shows pairwise correlations between the
28 tissue types based on mRNA expression levels of all
20,314 genes. Testis and brain were identified as outliers,
while a clear connectivity and similarities in global expres-
sion was observed between samples from the GI-tract, the
hematopoietic tissues, as well as the two striated muscle
tissues, respectively. Cardiac and skeletal muscle showed
highest correlations with one another as compared to
other tissue types.
The variance between muscle samples from different
individuals was analyzed by pairwise correlations of the
expression level of all protein coding genes (Fig. 2a–d).
A Spearman correlation of 0.97 was observed between
cardiac muscle samples from two different individuals
(Fig. 2a), while corresponding correlation for the skeletal
muscle samples was also 0.97 (Fig. 2b). The correlation
between average values from the two striated muscles
was somewhat lower (Fig. 2c), but still at a high value
(0.89). Low inter-individual variations in the genome-
wide expression patterns across muscle samples indicate
both high technical reproducibility and low biological
variance. Pairwise comparisons between muscle tissues
and other tissue types showed, as expected, higher vari-
ance. The lowest correlation was found between skeletal
muscle and testis (0.69, data not shown), while a some-
what surprisingly high correlation (0.90) was observed
between heart muscle and adipose tissue (Fig. 2d), as
well as skeletal muscle and adipose tissue (0.86, data not
shown). The similarity of global expression between adi-
pose tissue and the striated muscle is interesting and
should be explored further.
The cardiac muscle transcriptome
Data from the transcriptomics analysis across 28 tissue
types was used for categorization of all the protein-coding
genes (n = 20,314) into various classes of tissue-specific
expression. Figure 2e shows the classification for heart
muscle. Altogether 64 % of the genes were expressed in
the heart, with the largest class of genes (n = 8760) repre-
senting “housekeeping genes” expressed in all tissues, out
of which 641 genes encoded mitochondrial proteins. Only
283 genes were defined as elevated in heart as compared
to the other tissues (Additional file 1: Table S1), including
genes enriched in a group of tissues. The 283 genes
elevated in heart were classified into three subcategor-
ies as defined in Table 1, with 32 tissue enriched genes,
143 group enriched genes and 108 tissue enhanced
genes. A GO-analysis of these genes indicated an over-
representation of genes related to contraction (37 genes),
ion transport (23 genes), regulation of membrane potential
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(22 genes) and actomyosin structure organization (18
genes).
Of the 283 genes elevated in cardiac muscle, 47 genes
were differentially expressed between the two auricular
samples and the two ventricle samples (Additional file 2:
Table S2), based on mean values and a threshold of at
least a five-fold difference in FPKM values. Twenty-one
genes showed a higher average expression in the ven-
tricle samples as compared to the auricle samples, while
26 genes were higher expressed in the auricle samples
as compared to the ventricle samples. A majority of the
differentially expressed genes encode proteins associated
with developmental processes or regulatory functions
such as control of blood volume, blood pressure, heart
rate and response to cardiac overload. The list also
includes several genes with unknown or only partly
characterized functions in cardiac muscle.
An analysis of the expression levels of each gene made
it possible to calculate the relative mRNA pool in heart
for each category. The analysis (Fig. 2f) showed that 32 %
of the mRNA molecules present in heart correspond to
mitochondrial proteins and only 14 % of the mRNA pool
represents genes elevated in heart. Thus, a large fraction
of the transcriptional activity in the heart relates to gener-
ation of energy with almost one third of the transcripts
encoding proteins implicated in energy metabolism.
The skeletal muscle transcriptome
Figure 2g shows the classification for skeletal muscle.
Altogether 55 % of the genes were expressed in skeletal
muscle, with 8760 “housekeeping genes”. Only 371 genes
(Additional file 3: Table S3) were defined as elevated in
skeletal muscle as compared to other tissues, including
110 tissue enriched genes, 149 group enriched genes and
112 tissue enhanced genes. A GO-analysis of these genes
indicated an over-representation of genes involved in
contraction (48 genes), actin filament-based processes (37
genes), muscle organ development (24 genes) and muscle
filament sliding (23 genes).
Analysis of the relative mRNA pool in skeletal muscle
(Fig. 2h) showed that 28 % correspond to mitochondrial
proteins and 28 % represent genes elevated in skeletal
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Fig. 1 Hierarchical clustering of human tissues. The relationship between the 100 tissue samples corresponding to 28 different tissues, based on
pairwise Spearman correlations
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muscle. Thus, most of the transcriptional activity in the
skeletal muscle also relates to energy generation, but
with a higher fraction of mRNA molecules encoding
genes classified as tissue elevated as compared to heart.
Together the two striated muscles have by far the high-
est fraction of transcripts encoding mitochondrial pro-
teins of all analyzed tissues (data not shown).
Genes with shared enriched expression in cardiac and
skeletal muscle
A network plot of the tissue and group enriched genes
in heart and skeletal muscle, respectively, was generated
in order to illustrate genes commonly expressed between
different tissue types (Fig. 3). The two tissues had 81 simul-
taneously enriched genes, suggesting common functions.
GO-analysis of these genes showed an overrepresentation
of genes associated with contraction (18 genes), actin
filament-based processes (15 genes), actomyosin structure
organization (10 genes) and muscle filament sliding (8
genes). Several genes were also shared between striated
muscles and cerebral cortex, and these genes are dominated
by genes for which the corresponding proteins are involved
in ion transport. Moreover, a number of genes were simul-
taneously enriched in striated muscles, adipose tissue and/
or liver, mainly represented by genes implicated in meta-
bolic processes and enzymatic activities.
Proteins with elevated expression in cardiac muscle
The proteins elevated in heart or skeletal muscle identi-
fied by the transcriptomics analysis were further studied
by antibody-based profiling using the publicly available
resource of TMA data within the Human Protein Atlas
(www.proteinatlas.org) portal cross-referenced with
the Cardiac Organellar Protein Atlas Knowledge base
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Fig. 2 Sample correlations and classification of all human protein coding genes. Scatter plots of FPKM values for all detected genes in a two
cardiac muscle samples, b two skeletal muscle samples, c cardiac muscle and skeletal muscle d and cardiac muscle and adipose tissue. e Pie
chart showing the classification of all genes in cardiac muscle, based on transcript abundance and number of tissues with expression. f Pie chart
showing the distribution of the expressed mRNA molecules in cardiac muscle. g Pie chart showing the classification of all genes in skeletal
muscle. h Pie chart showing the distribution of expressed mRNA molecules in skeletal muscle
Table 1 The genes with elevated expression in cardiac and/or skeletal muscle
Category Cardiac muscle Skeletal muscle Description
Tissue enriched 32 110 Five-fold higher mRNA levels in specified muscle tissue as compared to other tissues
Group enriched 143 149 Five-fold higher mRNA levels in a group of 2–7 tissues, included specified muscle tissue
Tissue enhanced 108 112 Five-fold higher mRNA levels in specified muscle tissue as compared to average levels
in all tissues
Elevated (total) 283 371 Total number of genes tissue enriched, group enriched or tissue enhanced in specified muscle tissue
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(www.heartproteome.org) [6] in order to determine
heart and skeletal muscle specificity and spatial and
cellular distribution of the expression. In total, 239 of
the 283 genes elevated in cardiac muscle, and 313 of
the 371 genes elevated in skeletal muscle had available
antibodies as part of the Human Protein Atlas project
and were studied with antibody-based profiling using
immunohistochemistry. Immunohistochemistry was per-
formed on TMA cores from 44 different normal tissues,
including heart and skeletal muscle samples from three
different individuals, respectively. The analyzed proteins
were divided into categories based on specificity of the ex-
pression, such as proteins selectively expressed in either
heart or skeletal muscle, or proteins found to be expressed
in both heart and skeletal muscle. Examples of proteins
with various functions and expression patterns in striated
muscles are described below.
An interesting analysis is to investigate proteins ele-
vated in heart, particularly in relation to skeletal muscle.
Examples of eight proteins related to contraction and
with highest expression in heart muscle are displayed in
Fig. 4a. The primary structural proteins in the cardio-
myocytes are myosin and actin filaments, related to con-
traction and forming a striated pattern observed in
electron microscopy. Examples of members of the my-
osin and actin families mainly expressed in heart muscle
include MYH6, MYL4, MYL7 and ACTC1. Another pro-
tein family related to muscular contraction is the tropo-
nin family, regulating the binding of myosin to actin via
conformation differences dependent on calcium ion con-
centration in the cells [7]. Two troponin family members
solely expressed in heart are TNNI3 and TNNT2. Other
examples include the myosin binding protein MYBPC3,
influencing contraction by cross-bridging in the sarco-
mere, and the calcium channel protein CACNA1C, regu-
lating contraction via mediation of calcium ion entry into
excitable cells.
A large number of proteins identified as highly
expressed in heart were implicated in homeostasis and
regeneration/repair, and some of these are displayed
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in Fig. 4b. In order to retain balanced levels of various
substances in the body, heart plays an important role in
homeostasis. One such example is the atrial natriuretic
peptide NPPA, controlling extracellular fluid volume and
electrolyte homeostasis. Mutations in NPPA are thought
to be responsible for the development of atrial fibrillation
(arrhythmia) [8]. Another example is AKAP6, involved in
controlling energy homeostasis and glycolysis. Heart re-
generation and repair have been extensively studied as
cardiomyocyte deficiency is the underlying cause of most
heart failures, and it is still debated as to what extent car-
diomyocytes are replaced in adult hearts [9]. Examples of
proteins expressed in heart suggested to play a role in re-
generation and repair include the stem cell protein NES
and the cell adhesion molecule BVES. NES is involved in
brain and eye development and has been suggested to
be involved in reparative vascularization and differenti-
ation of cardiac stem cells into striated cells following
ACTC1
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A
B
C
D
MYL4
CACNA1C
NPPA BVESNESAKAP6
ART3 FILIP1
CDH2 MYZAPATP1A3 PKP2
RAB9BPOPDC2
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100 µm
Fig. 4 Immunohistochemical staining of proteins elevated in cardiac muscle. a Examples of eight proteins related to muscle contraction (MYH6,
MYL4, MYL7, ACTC1, TNNI3, TNNT2, MYBPC3 and CACNA1C). CACNA1C was distinctly stained in sarcolemma and endothelial cells. b Examples of
four proteins related to homeostasis and regeneration/repair, with NPPA displaying granular cytoplasmic expression, AKAP6 observed in nuclear
membranes of cardiomyocytes, NES restricted to endothelial cells and BVES distinctly stained in sarcolemma. c Examples of eight proteins specific
for intercalated discs (ATP1A3, CDH2, MYZAP, PKP2, ART3, FILIP1, POPDC2 and RAB9B). d Examples of two proteins with unknown function in
cardiac muscle (SBK2 and SHD)
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myocardial infarction [10, 11]. NES displayed distinct posi-
tivity in endothelial cells of both heart and other tissue
types. BVES is involved in formation and regulation of
tight junction permeability and limited literature suggests
involvement in muscle regeneration [12].
Intercalated discs are defined as the connections be-
tween two adjacent cardiomyocytes, aiding in contrac-
tion of multiple cardiomyocytes simultaneously as a
unit, which is necessary for proper heart function. Exam-
ples of eight proteins distinctly expressed in intercalated
discs are displayed in Fig. 4c. Four of these (ATP1A3,
CDH2, MYZAP and PKP2) are well characterized in lit-
erature and involved in functions related to plasma
membrane ion exchange, cell adhesion, cell junctions
and desmosomes, respectively. For the remaining four
proteins (ART3, FILIP1, POPDC2 and RAB9B) no or
only limited literature exists on function in heart. ART3
has been suggested as an arginine-specific protein with
function in testis [13], distinctly stained also in the
present investigation, however, the additional high ex-
pression in intercalated discs has previously not been de-
scribed. FILIP1, with evidence only at transcript level, is
suggested to play a role in neuronal development and
showed highest expression in heart and brain, but the
exact function is unknown [14]. The transmembrane
protein POPDC2 has in few studies on mice and zebra-
fish been suggested to play a role in proper sinus node
function [15], but no previous studies suggest expression
in intercalated discs. RAB9B has limited literature on
membrane trafficking, but no data on expression in heart.
Interestingly, two proteins previously not characterized
in heart (SBK2 and SHD) were at the mRNA level se-
lectively expressed in both samples from the atrium and
not in the ventricular wall or in any of the other ana-
lyzed tissues. Immunohistochemically stained images of
SBK2 and SHD are displayed in Fig. 4d. SBK2 has evi-
dence of existence only inferred from homology, while
SHD is suggested to be an adapter protein with previous
evidence only at transcript level.
Proteins with elevated expression in skeletal muscle
Similar to heart muscle, the main function of skeletal
muscle is contraction. Four proteins related to contrac-
tion with exclusive expression in skeletal muscle are dis-
played in Fig. 5a. Two of those (MYH2 and TNNT1) are
members of the myosin and troponin families. Other ex-
amples include the myosin binding protein MYBPC1
and the actin cross-linking protein MYOT, involved in
myofibril stability and assembly. MYH2 was expressed in
fast (type II) fibers [16] and TNNT1 in slow (type I) fi-
bers [17], while expression of MYOT was concentrated
to Z-lines of the muscle fibers.
In both heart and skeletal muscle, contraction is
dependent on the level of intracellular calcium. However,
in contrast to cardiomyocytes, where calcium release is
regulated via binding of external calcium ions to voltage
gated calcium channels, skeletal myocytes store calcium
in the sarcoplasmic reticulum until a neuronal impulse
triggers calcium influx along the myofilaments. In Fig. 5b,
four proteins related to calcium function with selective
expression in skeletal muscle are displayed. Two of the
main proteins responsible for this function are RYR1,
the ryanodine receptor acting as the calcium release
channel, and CASQ1, essential for calcium storage in
the sarcoplasmic reticulum. CAPN3 is an intracellular
protease regulated by changes in calcium levels and plays
a role in skeletal muscle degradation and sarcomeric re-
modeling, with defects resulting in muscular dystrophy
[18]. Another protein involved in calcium function is
JPH1, aiding in the functional cross-talk between cell sur-
face and intracellular calcium release channels.
Contraction is an energy demanding process and it is
acknowledged that skeletal muscle is a tissue with high
metabolic activity. Skeletal muscle is one of the body’s
major sites for glucose disposal and is implicated in
metabolic diseases such as type II diabetes. Thus, en-
zymatic activity is an important function in skeletal
muscle, relating to various processes such as glucose
metabolism, glycogen storage and regeneration. Indeed,
a large number (72 out of 371) of the elevated proteins
in skeletal muscle are related to different metabolic pro-
cesses, i.e. present in the HMR2.0 metabolic reaction li-
brary [19, 20]. Genes from several enzymatic pathways
were elevated in skeletal muscle, including membrane
transport, protein modification and purine metabolism.
The skeletal muscle specific transport reactions involved
calcium transport (ATP2A1, ATP2B2, nucleoside uptake
(SLC29A2) and glucose transport (SLCA4). Additional
examples of proteins implicated in enzymatic activities
with selective expression in skeletal muscle are displayed
in Fig. 5c. These examples include (i) AMPD1, an en-
zyme involved in the purine nucleotide cycle, (ii) PYGM,
an enzyme essential for carbohydrate metabolism and
glycogenolysis, (iii) CA3, a metalloenzyme catalyzing hy-
dration of carbon dioxide, and (iv) ENO3, an isoenzyme
suggested to play a role in muscle development and re-
generation, with mutations associated with glycogen
storage disease [21]. At the protein level, ENO3 was
highly expressed in type II fibers [22].
Four examples of proteins selectively expressed, but
with unknown function in skeletal muscle are displayed
in Fig. 5d. The putative protein FAM166B showed add-
itional positivity in adrenal gland and ciliated cells in the
present investigation. KLHL40 is suggested to be required
for skeletal muscle development [23]; however, the exact
function is unknown. Another example is OR10AB1P,
with evidence of existence only at the transcript level ac-
cording to Uniprot. Despite low FPKM values, OR10AB1P
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was selectively expressed in striated muscles as compared
to other tissues, with strongest immunoreactivity observed
in skeletal muscle. PHKG1 is the catalytic subunit of the
phosphorylase b kinase (PHK), which is responsible for
hormonal regulation of glycogen breakdown [24]; how-
ever, PHKG1 only has evidence of existence at the tran-
script level according to Uniprot and the exact function is
unknown. FAM166B, OR10AB1P and PHKG1 displayed a
heterogeneous expression pattern possibly representing
type I or type II muscle fibers.
Proteins with elevated expression in both cardiac and
skeletal muscle
Although heart and skeletal muscles differ in arrange-
ment of cells and response to signals, the two muscle
types have many similarities. Several proteins related to
contraction are shared between the two organs, as
displayed in Fig. 6a. Some of these are members of the
myosin and troponin families, such as MYH7, MYL3
and TNNC1. Another example is TPM3, a member of
the tropomyosin family essential for contraction. TPM3
binds to actin and is associated with the troponin com-
plex. In skeletal muscle, all four proteins were higher
expressed in type I muscle fibers.
In Fig. 6b, four proteins involved in calcium transport
and storage expressed in both heart and skeletal muscle
are shown. CAMK2B is involved in synapse formation
and regulation of sarcoplasmic reticulum calcium trans-
port [25]. Additional strong staining of CAMK2B was
observed in the CNS. Other examples include CASQ2,
responsible for the internal calcium store in muscle [26],
HRC, implicated in regulation of calcium sequestration
and release [27], and the calcium transport regulating
protein SRL, with evidence of existence only at the tran-
script level according to Uniprot.
Examples of proteins involved in metabolism and myofi-
brillar organization with expression shared between heart
and skeletal muscle are displayed in Fig. 6c. CKM is a cre-
atine kinase involved in energy transduction, and is also
an important serum marker for myocardial infarction
[28]. Another enzyme is PGAM2, related to glycolytic
pathways, with mutations causing glycogen storage disease
CASQ1RYR1
MYH2 MYBPC1 MYOT
CAPN3
A
C
D
TNNT1
JPH1
AMPD1 CA3PYGM ENO3
FAM166B KLHL40 OR10AB1P PHKG1
B
100 µm
Fig. 5 Immunohistochemical staining of proteins elevated in skeletal muscle. a Examples of four proteins related to muscle contraction (MYH2,
TNNT1, MYBPC1 and MYOT). MYH2 and TNNT1 were differentially expressed between type I and type II muscle fibers, while MYOT concentrated
to Z-lines of the muscle fibers. b Examples of four proteins related to calcium function (RYR1, CASQ1, CAPN3 and JPH1) (c) Examples of four
proteins related to enzymatic activity (AMPD1, PYGM, CA3 and ENO3). AMPD1 and PYGM revealed heterogeneous cytoplasmic expression and
ENO3 was differentially expressed between type I and type II muscle fibers. d Examples of four proteins with unknown function in skeletal muscle
(FAM166B, KLHL40, OR10AB1P and PHKG1). Both OR10AB1P and PHKG1 being differentially expressed between type I and type II muscle fibers
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AB
C
D
MYH7 MYL3 TNNC1
CAMK2B CASQ2 HRC SRL
CKM PGAM2 LDB3 MURC
ADSSL1 HHATL C1ORF170 SPTB
Cardiac 
muscle
Skeletal
muscle
Cardiac
muscle
Skeletal
muscle
Cardiac 
muscle
Skeletal
muscle
Cardiac 
muscle
Skeletal
muscle
TPM3
100 µm
Fig. 6 Immunohistochemical staining of proteins elevated in both cardiac and skeletal muscle. a Examples of four proteins related to muscular
contraction (MYH7, MYL3, TNNC1 and TPM3), in skeletal muscle higher expressed in type I muscle fibers. b Examples of four proteins related to
calcium transport and storage (CAMK2B, CASQ1, HRC and SRL). c Examples of four proteins related to metabolism and myofibrillar organization
(CKM, PGAM2, LDB3 and MURC). LDB3 was restricted to Z-lines of cardiac muscle fibers while more homogeneous in skeletal muscle. MURC
showed distinct expression of sarcolemma in both cardiac and skeletal muscle. d Examples of four proteins with unknown function in cardiac
and skeletal muscle, with ADSSL1 showing distinct nuclear staining, HHATL and C1ORF170 displaying cytoplasmic positivity, and SPTB revealing
distinct immunoreactivity in sarcolemma, accompanied with positivity in erythrocytes
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[29]. LDB3 is involved in sarcomere organization, with
mutations associated with myopathy [30]. MURC aids in
myofibrillar organization and has also been shown to in-
duce NPPA transcription [28, 31].
Four proteins with selective expression but unknown
function in heart and skeletal muscle are displayed in
Fig. 6d. The nuclear protein ADSSL1 has limited data
suggesting contribution to glycolysis, while vague litera-
ture on HHATL mentions heart specificity [32], how-
ever, the exact function is unknown and neither ADSSL1
nor HHATL has previously been characterized on the
protein level. Another protein only characterized on the
transcript level is C1ORF170, which regulates the ex-
pression of target genes associated with energy transfer
and contractile function [33]. SPTB is known to be in-
volved in cytoskeletal structure of erythrocyte plasma
membrane [34], and erythrocytes were distinctly stained
also in the present investigation, however, the clear
membranous expression in striated muscle cells has pre-
viously not been described.
Discussion
To our knowledge, this is the first study utilizing an in-
tegrative omics approach comparing heart and skeletal
muscle specific gene expression providing a detailed
genome-wide transcriptomics overview characterizing
normal striated muscles in relation to a broad range of
other tissues. The tissue specific RNA levels were com-
pared to corresponding in situ protein expression, by thor-
ough visual examination of the immunohistochemical
images provided by an antibody-based profiling approach.
In this way, the muscle specific genes could be further
stratified into different subcompartments present within
the striated muscles. This allowed us to identify proteins
with previously unknown patterns of expression, such as
FILIP1 and POPDC2 distinctly expressed in intercalated
discs of cardiac muscle. Using this approach, we were also
able to identify novel proteins specifically expressed in
myocytes and not present in other cell types in the sam-
ples, such as adipocytes, fibroblasts or endothelial cells,
which suggests a role of these proteins in striated muscle
physiology and function.
The immunohistochemistry-based profiling was per-
formed within the infrastructure of the Human Protein
Atlas program, a multidisciplinary research initiative
which systematically generates and validates represen-
tative antibodies towards all non-redundant human
proteins [35, 36]. In addition to performing immuno-
histochemistry on tissues with a well-established protocol,
the antibodies are thoroughly tested in various other
platforms such as protein arrays, Western blotting and
cell lines, suggesting a high quality of the generated
data. Data and high-resolution images from all ap-
proved antibodies together with the RNA-seq data for
each gene are comprehensively published online at
www.proteinatlas.org, which allows for further inter-
pretation and analysis of the genes and proteins pre-
sented here.
The analysis of the heart muscle elevated proteins is
well in line with the function of the heart. The list in-
cludes well-known proteins of the myosin, actin and
troponin families, as well as the natriuretic peptides A
and B, extensively studied as markers for heart failure
[37]. In addition, several proteins previously not described
in the context of heart were identified, such as the puta-
tive proteins SBK2 and SHD, selectively expressed in the
atrium and not in the ventricle or in any of the other ana-
lyzed tissues. Other identified examples of proteins with
yet unknown function include proteins expressed in inter-
calated discs, such as ART3, FILIP1, POPDC2 and
RAB9B. The exact functions of these proteins remain to
be elucidated, but given the selective expression in heart
muscle at both the mRNA and protein level, an implica-
tion in heart physiology can be anticipated. Similarly, the
analysis of skeletal muscle elevated proteins identified a
large number of proteins with well-known function re-
lated to contraction, calcium storage and enzymatic activ-
ity, but also several proteins previously not characterized
in skeletal muscle. As expected, a significant number of
proteins were expressed in both heart and skeletal muscle,
but our lists also included proteins unique for one of the
organs. An interesting observation is the high correlation
between striated muscles and adipose tissue, which may
partly be explained by presence of adipocytes in the heart
and skeletal muscle samples, but it possibly also has a
functional relevance related to metabolic activities.
Another interesting observation is that more than 30 %
of the transcripts in heart and 28 % of the transcripts
in skeletal muscle correspond to genes encoding mito-
chondrial proteins, which demonstrates the extreme
specialization of both the heart and skeletal muscle to
provide energy for the contraction. These two striated
muscle tissues consequently have a higher fraction
of mitochondrial transcripts than any of the other ana-
lyzed tissues. Mitochondrial genes were among the
most abundant genes in striated muscles, and often
showed FPKM values > 10,000. The natriuretic pep-
tides A and B (NPPA and NPPB) and several genes as-
sociated with contraction were also relatively highly
expressed. Interestingly, the lists of genes elevated in
striated muscles included several genes with low
mRNA abundance that were shown to be selectively
expressed in cardiac or skeletal muscle also at the pro-
tein level, suggesting that these genes may have a regu-
latory function. Two such examples are BVES and
RAB9B, distinctly expressed in membranes of cardio-
myocytes and intercalated discs, respectively, both with
FPKM values around 20.
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It is important to point out that the heart samples
used in the present investigation are taken from pa-
tients with various cardiovascular diseases and that the
sample size is rather small. Although it cannot be ruled
out that an underlying disease alters transcription of
individual genes, the global expression profiles were
shown to be highly similar between samples despite
different disease background of the patients. Given
that a large number of the genes identified as most
abundant in heart represented genes associated with a
well-known function and no overrepresentation of
genes associated with other pathological conditions
was observed, a good estimate of a normal mRNA pro-
file can be anticipated.
From a medical point of view, the identification of the
molecular constituents of the cardiac and skeletal muscle
is important. Despite the high prevalence of myocardial
infarction, the diagnosis remains a challenge as routine
signs and symptoms have low specificity and sensitivity.
Myocardial infarction may occur without symptoms,
stressing the need for other diagnostic methods such as
cardiac imaging or biomarker alterations. Research on
serum-based biomarkers has identified several proteins
that may serve as markers of cardiomyocyte injury, such
as troponins, CKMB and MYL1 [3, 38]. Moreover, the
natriuretic peptides NPPA and NPPB have been exten-
sively studied as diagnostic and prognostic biomarkers in
acute heart failure patients, showing promising results
[37]. However, although alterations in these biomarkers
may reflect myocardial necrosis or cardiac overload, more
biomarkers are needed in order to identify and stratify
high-risk individuals and further understand the under-
lying mechanisms. The data presented here can serve as a
starting point for further biomarker discovery, since the
gene expression repository can be used for identifying
muscle specific biomarkers that are unique or common
for different types of muscles.
Conclusions
In summary, our work presents a comprehensive re-
source of proteins elevated in cardiac and skeletal
muscle that have been identified and localized to specific
muscle segments. This resource can be used for further
molecular studies on striated muscle biology as well as
for research studies comparing normal and pathological
tissues.
Methods
Tissue samples
Tissues used for RNA extraction was based on biopsies
from four heart muscle samples and five skeletal muscle
samples. The heart material was composed of two sam-
ples from the left ventricle (both adult females) and two
samples from the left auricles (one female and one male,
both adults). One left ventricle sample was obtained by
surgery for asymmetrical hypertrophy, with the sample
showing slight fibrosis, but not diagnostic for hyper-
trophic cardiomyopathy. The other left ventricle sample
was obtained from an individual diagnosed with post
partum cardiomyopathy, with the material taken in
connection with temporary use of left ventricle device
(heart mate). The sample had some dilation and slight
endocardial increased thickness. The histology of the
sample was mainly normal, but also showed areas with
increased fibrotic tissue and compensatory hyper-
trophy, as well as a slight probably unspecific inflam-
mation. Both auricle samples were obtained from
individuals operated for atrial fibrillation, with normal
histological picture without amyloid depositions. The
five skeletal muscle samples (two males and three fe-
males) were derived from the vastus lateralis muscle in
adult healthy volunteers [39]. In addition, samples
from 26 other tissues and organs were analyzed, as pre-
viously described [4].
Transcript profiling (RNA-seq)
The use of human tissue samples was approved by the
Uppsala Ethical Review Board (Reference #2011/473).
Tissues samples were embedded in Optimal Cutting
Temperature (O.C.T.) compound and stored at −80 °C.
A hematoxylin-eosin (HE) stained frozen section (4 μm)
was prepared from each sample using a cryostat and
each slide was examined by a pathologist to ensure
proper tissue morphology and sampling of representative
normal tissue. Three sections (10 μm) were cut from
each frozen tissue block and collected into a tube for
subsequent RNA extraction. The tissue was homoge-
nized mechanically using a 3 mm steel grinding ball
(VWR). Total RNA was extracted from cell lines and
tissue samples using the RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s in-
structions. For the skeletal muscle samples, RNA was
extracted using the Trizol® method (Invitrogen, Carlsbad,
CA, USA). The extracted RNA samples were analyzed
using either an Experion automated electrophoresis sys-
tem (Bio-Rad Laboratories, Hercules, CA, USA) with
the standard-sensitivity RNA chip or an Agilent 2100
Bioanalyzer system (Agilent Biotechnologies, Palo Alto,
USA) with the RNA 6000 Nano Labchip Kit. Only sam-
ples of high-quality RNA (RNA Integrity Number ≥7.5)
were used in the following mRNA sample preparation
for sequencing. mRNA sequencing was performed on
Illumina HiSeq2000 and 2500 machines (Illumina, San
Diego, CA, USA) using the standard Illumina RNA-seq
protocol with a read length of 2 × 100 bases. The
samples were sequenced multiplexed 15 per lane, pro-
ducing an average of 18 million mappable read pairs per
sample.
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Analysis of data
The raw reads obtained from the sequencing system
were trimmed for low quality ends with the software
Sickle (3), using a phred quality threshold of 20. All
reads shorter than 54 bp after the trimming were discarded.
The processed reads were mapped to the GRCh37 version
of the human genome with Tophat v2.0.3 (4). Potential
PCR duplicates were eliminated using the MarkDuplicates
module of Picard 1.77 (5). To obtain quantification scores
for all human genes and transcripts, FPKM (fragments per
kilobase of exon model per million mapped reads) values
were calculated using Cufflinks v2.0.2 (6), which corrects
for transcript length and the total number of mapped reads
from the library to compensate for different read depths for
different samples. The gene models from Ensembl build
69 (7) were used in Cufflinks. Data was analyzed using R
Statistical Environment (8) with the addition of package
‘gplots’ (9). A network analysis was performed using
Cytoscape 3.0 (10). For analyses where a log2-scale of the
data was used, pseudo-counts of +1 were added to the
values.
Specificity classification
The average FPKM value of all individual samples for
each tissue was used to estimate the gene expression
level and classify the 20,314 genes into one of six
categories: (1) “Not detected”, <1 FPKM in tissue; (2)
“Tissue enriched”, at least five-fold higher FPKM level in
tissue compared to all other 27 tissues; (3) “Group
enriched”, at least five-fold higher FPKM level in a group
of 2–7 tissues compared to all other tissues; (4)
“Expressed in all”, detected in all 28 tissues; (5) “Tissue
enhanced”, at least five-fold higher FPKM level in tissue
compared to the average FPKM value of all 28 tissues
and (6) “Mixed”, genes expressed in 1–27 tissues and in
none of the above categories. A tissue-specific score [4]
was defined as the heart or skeletal muscle FPKM re-
spectively, divided by the maximum FPKM value in
any of the other 27 tissues. Genes categorized as tissue
enriched, group enriched or tissue enhanced were
together defined as tissue elevated, while genes in the
“expressed in all” category were further classified into
a “mitochondrial” category based on a list of mitochon-
drial proteins obtained from the MitoProteome data-
base [40].
Gene ontology analysis
A gene ontology (GO) [41] analysis was performed using
the GOrilla tool [42] in order to determine overrepre-
sented GO categories in the gene set of tissue elevated
genes. The number of genes for each term was counted,
allowing a gene to be associated with more than one
term. A list of all genes analyzed in this study was used
as the background list in GOrilla.
Tissue profiling
Tissue microarrays (TMAs) were generated as previously
described [43], containing 1 mm cores of 44 different
normal tissues in triplicates. Formalin-fixed and paraffin-
embedded samples were received from the Department of
Pathology, Uppsala University Hospital, Sweden, approved
by the local Research Ethics Committee (Uppsala, Sweden,
Ups 02–577). One section (4 μm) was cut from each
donor block, stained with HE and reviewed by a patholo-
gist in order to select the appropriate area for sampling.
Cylindrical cores with a diameter of 1 mm cylindrical
tissue core were removed from the donor blocks and
placed into recipient paraffin blocks, using an TMA
Grand Master (3DHistech, Budapest, Hungary).
Four-micrometer sections were cut from the TMA
blocks, mounted on adhesive slides and baked at 60 °C
for 45 min. TMA slides were then deparaffinised in
Neo-Clear® (Merck Millipore, Darmstadt, Germany),
followed by hydration in graded alcohols and blocking
for endogenous peroxidase in 0.3 % hydrogen peroxide.
For antigen retrieval, slides were immersed and boiled
in Citrate buffer®, pH6 (Lab Vision, Freemont, CA) for
4 min at 125 °C and then allowed to cool to 90 °C. Au-
tomated IHC was performed essentially as previously
described [43], using an Autostainer 480 instrument®
(Lab Vision). Primary antibodies and a dextran poly-
mer visualization system (UltraVision LP HRP poly-
mer®, Lab Vision) were incubated for 30 min each at
room temperature and slides were developed for 10 min
using Diaminobenzidine (Lab Vision) as chromogen. All
incubations were followed by rinse in Wash buffer® (Lab
Vision) for 5 min. Slides were counterstained in Mayers
hematoxylin (Histolab) and cover slipped using Pertex®
(Histolab) as mounting medium. Incubation with PBS
instead of primary antibody served as negative control.
The dilution of the primary antibody was optimized by
testing the antibody on a selection of normal tissues and
comparison with previously published literature and gene
characterization data. The AperioScanScope XT Slide
Scanner (Aperio Technologies, Vista, CA) system was
used to capture digital whole slide high-resolution images
with a 20× objective.
Antibodies
The IDs of all antibodies used in the immunohistochemi-
cally stained images are summarized here. All antibodies
are from the Human Protein Atlas project, unless other-
wise stated. Proteins elevated in cardiac muscle: MYH6
(HPA001239), MYL4 (HPA051884), MYL7 (HPA013331),
ACTC1 (61075, PROGEN Biotechnik), TNNI3 (HPA063258),
TNNT2 (HPA015774), MYBPC3 (HPA040147), CACNA1C
(HPA039796), NPPA (HPA058269), AKAP6 (07–087, Up-
state), NES (HPA026111), BVES (HPA014788), ATP1A3
(HPA045367), CDH2 (sc-8424, Santa Cruz Biotechnology),
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MYZAP (HPA039827), PKP2 (HPA014314), ART3
(HPA011268), FILIP1 (HPA055754), POPDC2 (HPA024255),
RAB9B (HPA061932), SBK2 (HPA030631), SHD
(HPA017955). Proteins elevated in skeletal muscle:
MYH2 (M4276, SIGMA), TNNT1 (HPA058448), MYBPC1
(HPA021004), MYOT (HPA037733), RYR1 (HPA056416),
CASQ1 (HPA026823), CAPN3 (HPA040052), JPH1
(HPA009413), AMPD1 (HPA028080), PYGM (HPA056003),
CA3 (H00000761-M02, Abnova), ENO3 (HPA000793),
FAM166B (HPA045540), OR10AB1P (HPA044992),
PHKG1 (HPA012057). Proteins elevated in both car-
diac and skeletal muscle: MYH7 (sc-53090, Santa Cruz
Biotechnology), MYL3 (sc-47719, Santa Cruz Biotech-
nology), TNNC1 (NCL-TROPC, Novocastra), TPM3
(HPA047089), CAMK2B (HPA026307), CASQ2 (HPA
027285), HRC (HPA004833), SRL (HPA041535), CKM
(HPA047859), PGAM2 (HPA060173), LDB3 (HPA048955),
MURC (HPA020973), ADSSL1 (HPA052621), HHATL
(HPA018174), C1ORF170 (HPA031712), SPTB (HPA003398).
Data availability
FPKM values for samples from all analyzed tissues ex-
cept skeletal muscle are available for download without
any restrictions (www.proteinatlas.org/about/download).
The skeletal muscle data will be added to the next release
of the Human Protein Atlas. The primary data (reads)
are available through the Array Express Archive
(www.ebi.ac.uk/arrayexpress/) under accession number
E-MTAB-1733, as well as at Gene Expression Omnibus
under the accession numbers GSE58387 and GSE58608.
Transcript profiling data for each gene in each tissue type,
as well as the original immunohistochemically stained im-
ages are also available on the Human Protein Atlas
(www.proteinatlas.org).
Additional files
Additional file 1: Table S1. List of the 283 genes elevated in cardiac
muscle. The list is sorted after tissue-specific score which is the FPKM
value in cardiac muscle divided by the maximum FPKM in all other
tissues.
Additional file 2: Table S2. List of 47 genes elevated in cardiac muscle
and differentially expressed between ventricle and auricle samples. The
list includes genes showing at least a five-fold difference between mean
FPKM values of ventricle and auricle samples, respectively.
Additional file 3: Table S3. List of the 371 genes elevated in skeletal
muscle. The list is sorted after tissue-specific score which is the FPKM
value in skeletal muscle divided by the maximum FPKM in all other
tissues.
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